The Latest Cardiac and Vascular News
Topline Results from GALACTIC-HF, Phase 3 Clinical Trial of Omecamtiv Mecarbil, Cardiac Myosin Activator, Expected in Q4 Licensing Collaboration and Royalty Monetization Deals with Xi Jing Pharmaceuticals and RTW Investments Accelerate and Expand Development of CK-3773274, Next Generation Cardiac Myosin Inhibitor Leveraging Partnerships to Finance Build of Commercial Business SOUTH SAN FRANCISCO, […]
Accelerated Commercialization Due to COVID-19 Will Enable Providers to Offer Optimized, Efficient Care BRISBANE, Calif., July 15, 2020 /PRNewswire/ — Caption Health, a leading medical artificial intelligence (AI) company, closed its Series B funding round with $53 million to further develop and commercialize its FDA-cleared, AI-guided ultrasound technology that expands patient access to high-quality […]
ENGLEWOOD, Colo., July 14, 2020 /PRNewswire/ — Zynex, Inc. (“Zynex”) (Nasdaq: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today the pricing of its previously announced underwritten public offering of an aggregate of 2,500,000 shares of its […]
Company Sees Record Growth for Its Technology Powered by Deep Learning and Artificial Intelligence MINNEAPOLIS, July 15, 2020 /PRNewswire/ — Preventice Solutions, a leader in digital healthcare solutions and remote cardiac monitoring services powered by deep learning and artificial intelligence (AI), today announced that it has raised $137M in a Series B financing to accelerate […]
PLANO, Texas, July 15, 2020 (GLOBE NEWSWIRE) — Integer Holdings Corporation (“Integer”) (NYSE: ITGR), a leading medical device outsource manufacturer, announced that the United States Court of Appeals for the Federal Circuit affirmed yesterday, in all respects, the judgment in its favor granted in the United States District Court for […]
Launches Indigo® System Lightning™ 12 in U.S. Appoints Corey L. Teigen, M.D., as Chief Scientific Officer and James F. Benenati, M.D., FSIR, as Chief Medical Officer ALAMEDA, Calif.–(BUSINESS WIRE)–Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced its next phase for vascular franchise growth with U.S. […]
Verizon to Integrate the Bioflux® Solution into their EMS and Launch to Existing and Future Customers REDWOOD CITY, Calif., July 14, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company announced a strategic partnership with Verizon (NYSE: VZ) to develop EMS solutions for First Responders by integrating […]
Robert S. White Joins Board of Directors SANTA CLARA, Calif., July 14, 2020 (GLOBE NEWSWIRE) — Cardiva Medical, Inc, an innovator in the field of vascular closure, today announced the completion of a $45 million equity financing round. The equity round included new investor EW Healthcare Partners in addition to […]
NEW HOPE, Pa., July 13, 2020 (GLOBE NEWSWIRE) — Orchestra BioMed, Inc. (“Orchestra BioMed” or the “Company”), a biomedical innovation company focused on developing transformative therapeutic products for large unmet needs in procedure-based medicine, today announced the appointment of Jagdish Parasrampuria M.Pharm., Ph.D., as Vice President of Pharmaceutical Development. Dr. Parasrampuria […]
$250 Million in Committed Capital to Cytokinetics; Additional $200 Million in Development and Commercialization Milestone Payments Ji Xing Pharmaceuticals to Develop & Commercialize in China RTW Provides Access to Capital to Cytokinetics to Fund Global Development in Exchange for Potential Royalties and Agrees to Purchase Royalty on Mavacamten Company to Host […]
